CSS LLC’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,702
| Closed | -$6.05K | – | 678 |
|
|
2025
Q1 | $6.05K | Hold |
30,702
| – | – | ﹤0.01% | 618 |
|
|
2024
Q4 | $16.5K | Hold |
30,702
| – | – | ﹤0.01% | 620 |
|
|
2024
Q3 | $29.2K | Hold |
30,702
| – | – | ﹤0.01% | 552 |
|
|
2024
Q2 | $29.9K | Hold |
30,702
| – | – | ﹤0.01% | 526 |
|
|
2024
Q1 | $48.5K | Hold |
30,702
| – | – | ﹤0.01% | 512 |
|
|
2023
Q4 | $24.3K | Sell |
30,702
-60,000
| -66% | -$47.6K | ﹤0.01% | 501 |
|
|
2023
Q3 | $70.7K | Hold |
90,702
| – | – | ﹤0.01% | 496 |
|
|
2023
Q2 | $83.9K | Buy |
+90,702
| New | +$83.9K | 0.01% | 495 |
|